학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 675건 | 목록 1~20
Academic Journal
International Journal for the Scholarship of Teaching and Learning. 2024 18(1).
Academic Journal
Front Cell Dev Biol
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Fagnano, E, Pendharkar, S, Colton, M, Jones, P N, Sallan, M C, Klymenko, T, Braun, A, Klein, C, Honeychurch, J, Cheadle, E J & Illidge, T M 2023, 'Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies', Frontiers in cell and developmental biology, vol. 11, 1270398. https://doi.org/10.3389/fcell.2023.1270398
Academic Journal
Pun N; Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Cytlak UM; Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Lee D; Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Domingues RG; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Cheadle EJ; Targeted Therapy Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M20 4BX, United Kingdom.; Forster D; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Whiteley C; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Honeychurch J; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Williams KJ; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Graham GJ; Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TT, United Kingdom.; Hepworth MR; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom.; Travis MA; Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom. Electronic address: mark.travis-2@manchester.ac.uk.; Illidge TM; Targeted Therapy Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M20 4BX, United Kingdom. Electronic address: tim.illidge@manchester.ac.uk.; Dyer DP; Wellcome Centre for Cell-Matrix Research, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, United Kingdom; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, United Kingdom. Electronic address: douglas.dyer@manchester.ac.uk.
Publisher: Elsevier Country of Publication: United States NLM ID: 101299742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3456 (Electronic) Linking ISSN: 19330219 NLM ISO Abbreviation: Mucosal Immunol Subsets: MEDLINE
Academic Journal
Romano E; Division of Cancer Sciences, Paterson Building, University of Manchester, Manchester, United Kingdom. Electronic address: erminia.romano@manchester.ac.uk.; Behan C; Cancer Research UK-Manchester Institute, Paterson Building, Manchester, United Kingdom.; Baker A; Cancer Research UK-Manchester Institute, Paterson Building, Manchester, United Kingdom.; Ashton G; Cancer Research UK-Manchester Institute, Paterson Building, Manchester, United Kingdom.; Honeychurch J; Division of Cancer Sciences, Paterson Building, University of Manchester, Manchester, United Kingdom. Electronic address: jamie.honeychurch@manchester.ac.uk.
Publisher: Academic Press Country of Publication: United States NLM ID: 0373334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0091-679X (Print) Linking ISSN: 0091679X NLM ISO Abbreviation: Methods Cell Biol Subsets: MEDLINE
Academic Journal
International Journal for the Scholarship of Teaching & Learning; 2024, Vol. 18 Issue 1, preceding p1-8, 9p
Academic Journal
EJNMMI Res
EJNMMI Research, Vol 9, Iss 1, Pp 1-13 (2019)
Vassileva, V, Stribbling, S M, Barnes, C, Carroll, L, Braga, M, Abrahams, J, Heinzmann, K, Haegeman, C, MacFarlane, M, Simpson, K L, Dive, C, Honeychurch, J, Illidge, T M & Aboagye, E O 2019, 'Evaluation of apoptosis imaging biomarkers in a genetic model of cell death', EJNMMI Research, vol. 9, 18. https://doi.org/10.1186/s13550-019-0487-8
Academic Journal
Gregucci F; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.; Spada S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Barcellos-Hoff MH; Department of Radiation Oncology, School of Medicine, University of California, San Francisco, CA, USA.; Bhardwaj N; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Chan Wah Hak C; Translational Immunotherapy Team, The Institute of Cancer Research, London, UK.; Fiorentino A; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.; Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy.; Guha C; Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.; Guzman ML; Division of Hematology/Oncology, Department of Medicine, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Harrington K; The Institute of Cancer Research/The Royal Marsden NHS Foundation Trust, National Institute for Health Research Biomedical Research Centre, London, UK.; Herrera FG; Centre Hospitalier Universitaire Vaudois, University of Lausanne and Ludwig Institute for Cancer Research at the Agora Cancer Research Center, Lausanne, Switzerland.; Honeychurch J; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Hong T; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Iturri L; Institut Curie, Université PSL, CNRS UMR3347, INSERM U1021, Signalisation Radiobiologie et Cancer, Orsay, France.; Jaffee E; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.; Karam SD; Department of Radiation Oncology, University of Colorado, Aurora, CO, USA.; Knott SRV; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Koumenis C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lyden D; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Marciscano AE; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Melcher A; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Mondini M; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; Université of Paris-Saclay, Saclay, France.; INSERM U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Villejuif, France.; Mondino A; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Morris ZS; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; Pitroda S; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, USA.; Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Santambrogio L; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.; Shiao S; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Stagg J; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Faculty of Pharmacy, Montreal, Canada.; Telarovic I; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.; Timmerman R; Departments of Radiation Oncology and Neurosurgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Vozenin MC; Laboratory of Radiation Oncology, Radiation Oncology Service, Department of Oncology, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Weichselbaum R; Department of Radiation and Cellular Oncology, Ludwig Center for Metastases Research, University of Chicago, IL, USA.; Welsh J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wilkins A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom, Royal Marsden Hospital, Sutton, UK.; Xu C; School of Applied and Engineering Physics, Cornell University, Ithaca, NY, USA.; Zappasodi R; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Zou W; Departments of Surgery and Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA.; Bobard A; Gustave Roussy Cancer Campus, Villejuif, France.; Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Galluzzi L; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.; Deutsch E; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; Université of Paris-Saclay, Saclay, France.; INSERM U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Villejuif, France.; Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Frankish J; Apogenix AG, Heidelberg, Germany.; Mukherjee D; Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Romano E; Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Billian-Frey K; Apogenix AG, Heidelberg, Germany.; Schröder M; Apogenix AG, Heidelberg, Germany.; Heinonen K; Apogenix AG, Heidelberg, Germany.; Merz C; Apogenix AG, Heidelberg, Germany.; Redondo Müller M; Apogenix AG, Heidelberg, Germany.; Gieffers C; Apogenix AG, Heidelberg, Germany.; Hill O; Apogenix AG, Heidelberg, Germany.; Thiemann M; Apogenix AG, Heidelberg, Germany.; Honeychurch J; Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Illidge T; Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Sykora J; Apogenix AG, Heidelberg, Germany.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Honeychurch, J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어